Fig. 3From: Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategiesGenomic alterations of PARP1/2/3 and BRCA1/2 in pediatric AML and ALL TARGET study and adult AML cohorts (Beat AML, TCGA-LAML and NGS-PTL). A Oncoprint of genomic alterations of PARP1, PARP2, PARP3, BRCA1 and BRCA2 acute leukemia cohorts. B Frequency and type of genomic alterationsBack to article page